home
portfolio
team
careers
contact
investor portal
home
portfolio
team
careers
contact
investor portal
Nextech Invest
ITM and POINT Biopharma Expand Global Supply Agreement for n.c.a. Lutetium-177
ITM and POINT Biopharma Expand Global Supply Agreement for n.c.a. Lutetium-177
Post navigation
Previous Post
Previous
Boundless Bio Appoints Jami Rubin as Chief Financial Officer
Next Post
Next
Revolution Medicines, Inc. to Acquire EQRx, Inc. in All-Stock Transaction to Gain More Than $1 Billion in Additional Capital